Correction: “Implications of COVID-19 for patients with pre-existing digestive diseases” (The Lancet Gastroenterology & Hepatology (2020) 5(5) (425–427), (S2468125320300765), (10.1016/S2468-1253(20)30076-5));Implications of COVID-19 for patients with pre-existing digestive diseases

The Lancet Gastroenterology and Hepatology

Volumn 5, Issue 5, 2020, Pages 426-428

  Mao, Ren ^a   Liang, Jie ^b   Shen, Jun ^c   Ghosh, Subrata ^d   Zhu, Liang Ru ^e   Yang, Hong ^f   Wu, Kai Chun ^b   Chen, Min Hu ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^e HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^f PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; IMMUNOSUPPRESSIVE AGENT; VIRUS RNA;

AUTOIMMUNE HEPATITIS; AUTOPSY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CLINICAL OUTCOME; COLORECTAL CANCER; COLORECTAL CARCINOMA; CORONAVIRUS DISEASE 2019; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIARRHEA; FECES ANALYSIS; GASTROINTESTINAL DISEASE; GASTROINTESTINAL INFECTION; HEPATITIS B; HUMAN; HYPERTENSION; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INTESTINE STENOSIS; ISCHEMIC HEART DISEASE; LIVER FUNCTION TEST; LIVER INJURY; LIVER TRANSPLANTATION; NAUSEA; NONALCOHOLIC FATTY LIVER; NOTE; PRIORITY JOURNAL; QUARANTINE; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VOMITING; BETACORONAVIRUS; CORONAVIRUS INFECTION; DIGESTIVE SYSTEM DISEASE; ISOLATION AND PURIFICATION; PANDEMIC; PATHOPHYSIOLOGY; VIROLOGY; VIRUS PNEUMONIA;

BETACORONAVIRUS; CORONAVIRUS INFECTIONS; DIGESTIVE SYSTEM DISEASES; HUMANS; INFLAMMATORY BOWEL DISEASES; PANDEMICS; PNEUMONIA, VIRAL;

EID: 85082426230     PISSN: 24681253     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2468-1253(20)30150-3     Document Type: Erratum

References (11)

1. Holshue, ML, DeBolt, C, Lindquist, S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med, 2020 published online March 5. DOI:10.1056/NEJMoa2001191.
2. Guan, W, Ni, Z, Hu, Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med, 2020 published online Feb 28. DOI:10.1056/NEJMoa2002032.
3. Liu, Q, Wang, R, Qu, G, et al. Macroscopic autopsy findings in a patient with COVID-19. J Forensic Med 36 (2020), 1–3 (in Chinese).
4. Zhang, C, Shi, L, Wang, FS, Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol, 2020 published online March 4 https://doi.org/10.1016/S2468-1253(20)30057-1.
5. Kumar, D, Tellier, R, Draker, R, Levy, G, Humar, A, Severe Acute Respiratory Syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening. Am J Transplant 3 (2003), 977–981.
6. The Transplantation Society. Guidance on coronavirus disease 2019 (COVID-19) for transplant clinicians. https://tts.org/23-tid/tid-news/657-tid-update-and-guidance-on-2019-novel-coronavirus-2019-ncov-for-transplant-id-clinicians (accessed March 3, 2020).
7. Liang, W, Guan, W, Chen, R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol, 2020 published online Feb 14. DOI:10.1016/S1470-2045(20)30096-6.
8. Mao, R, Chen, MH, Networked Clinical study collaboration on inflammatory bowel disease in China. Am J Gastroenterol, 113, 2018, 1266.
9. Chinse Society of, IBD, Managing IBD patients during the outbreak of COVID-19. Chin J Dig, 40, 2020, E001.
10. Crohn's Colitis Foundation. What IBD patients should know about the 2019 novel coronavirus (COVID-19). https://www.crohnscolitisfoundation.org/what-ibd-patients-should-know-about-2019-novel-coronavirus-covid-19 (accessed March 3, 2020).
11. Crohn's & Colitis, UK, Novel coronavirus (COVID-19) advice. https://www.crohnsandcolitis.org.uk/news/updated-wuhan-novel-coronavirus-advice (accessed March 3, 2020).